These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 21142899)
41. Antifungal drug resistance in pathogenic fungi. Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500 [TBL] [Abstract][Full Text] [Related]
42. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis. Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925 [TBL] [Abstract][Full Text] [Related]
43. In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi. Xu Y; Gao C; Li X; He Y; Zhou L; Pang G; Sun S J Ocul Pharmacol Ther; 2013 Mar; 29(2):270-4. PubMed ID: 23410063 [TBL] [Abstract][Full Text] [Related]
44. Determination of susceptibility/resistance to antifungal drugs of Trichophyton mentagrophytes isolates by a macrodilution method. Barros ME; Hamdan JS Can J Microbiol; 2005 Nov; 51(11):983-7. PubMed ID: 16333338 [TBL] [Abstract][Full Text] [Related]
45. Fusarium spp. as agents of onychomycosis in immunocompetent hosts. Guilhermetti E; Takahachi G; Shinobu CS; Svidzinski TI Int J Dermatol; 2007 Aug; 46(8):822-6. PubMed ID: 17651164 [TBL] [Abstract][Full Text] [Related]
46. How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton. Arendrup MC; Kahlmeter G; Guinea J; Meletiadis J; Clin Microbiol Infect; 2021 Jan; 27(1):55-60. PubMed ID: 32916260 [TBL] [Abstract][Full Text] [Related]
47. The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro. Cuenca-Estrella M; Rodriguez-Tudela JL Expert Rev Anti Infect Ther; 2010 Mar; 8(3):267-76. PubMed ID: 20192681 [TBL] [Abstract][Full Text] [Related]
48. Trends in antifungal susceptibility testing using CLSI reference and commercial methods. Cantón E; Espinel-Ingroff A; Pemán J Expert Rev Anti Infect Ther; 2009 Feb; 7(1):107-19. PubMed ID: 19622060 [TBL] [Abstract][Full Text] [Related]
49. An evaluation of the in vitro activity of terbinafine. Jessup CJ; Ryder NS; Ghannoum MA Med Mycol; 2000 Apr; 38(2):155-9. PubMed ID: 10817232 [TBL] [Abstract][Full Text] [Related]
50. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method. Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562 [TBL] [Abstract][Full Text] [Related]
51. Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis. Wiederhold NP; Fothergill AW; McCarthy DI; Tavakkol A Antimicrob Agents Chemother; 2014 Jun; 58(6):3553-5. PubMed ID: 24709260 [TBL] [Abstract][Full Text] [Related]
52. Molecular typing and antifungal susceptibility of Trichophyton rubrum isolates from patients with onychomycosis pre- and post-treatment. de Assis Santos D; de Carvalho Araújo RA; Kohler LM; Machado-Pinto J; Hamdan JS; Cisalpino PS Int J Antimicrob Agents; 2007 May; 29(5):563-9. PubMed ID: 17331707 [TBL] [Abstract][Full Text] [Related]
53. In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test. Kondori N; Svensson E; Mattsby-Baltzer I Mycoses; 2011 Sep; 54(5):e318-22. PubMed ID: 20557462 [TBL] [Abstract][Full Text] [Related]
54. In vitro antifungal and antibacterial activities of pentacycloundecane tetra-amines. Onajole OK; Coovadia Y; Govender T; Kruger HG; Maguire GE; Naidu D; Singh N; Govender P Chem Biol Drug Des; 2011 Apr; 77(4):295-9. PubMed ID: 21241455 [TBL] [Abstract][Full Text] [Related]
55. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis. Qiu WY; Yao YF; Zhu YF; Zhang YM; Zhou P; Jin YQ; Zhang B Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625 [TBL] [Abstract][Full Text] [Related]
56. Molecular characterization and antifungal susceptibility profile of dermatophytes isolated from scalp dermatophyte carriage in primary school children in Arak city, Center of Iran. Allahdadi M; Hajihossein R; Kord M; Rahmati E; Amanloo S; Didehdar M J Mycol Med; 2019 Apr; 29(1):19-23. PubMed ID: 30660447 [TBL] [Abstract][Full Text] [Related]
57. In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole. Santos DA; Hamdan JS Mycoses; 2007 Jul; 50(4):286-9. PubMed ID: 17576321 [TBL] [Abstract][Full Text] [Related]
58. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. Espinel-Ingroff A J Clin Microbiol; 2001 Apr; 39(4):1360-7. PubMed ID: 11283057 [TBL] [Abstract][Full Text] [Related]
59. In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole. Rudramurthy SM; Jatana M; Singh R; Chakrabarti A Mycoses; 2013 Jan; 56(1):39-46. PubMed ID: 22519679 [TBL] [Abstract][Full Text] [Related]
60. Comparison of a glucose consumption based method with the CLSI M38-A method for testing antifungal susceptibility of Trichophyton rubrum and Trichophyton mentagrophytes. Zhang J; Chen J; Huang HQ; Xi LY; Lai W; Xue RZ; Zhang XH; Chen RZ Chin Med J (Engl); 2010 Jul; 123(14):1909-14. PubMed ID: 20819577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]